Your browser doesn't support javascript.
loading
Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial.
Zaman, K; Yunus, Md; Aziz, Asma B; Feser, Jodi; Mooney, Jessica; Tang, Yuxiao; Ellison, Damon W; Thaisomboonsuk, Butsaya; Zhang, Lei; Neuzil, Kathleen M; Marfin, Anthony A; Letson, G William.
Afiliación
  • Zaman K; International Centre for Diarrheal Disease Research, 68, Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
  • Yunus M; International Centre for Diarrheal Disease Research, 68, Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
  • Aziz AB; International Centre for Diarrheal Disease Research, 68, Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh.
  • Feser J; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
  • Mooney J; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
  • Tang Y; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
  • Ellison DW; Armed Forces Research Institute of Medicine Sciences, 315/6 Rajvithi Rd., Bangkok 10400, Thailand.
  • Thaisomboonsuk B; Armed Forces Research Institute of Medicine Sciences, 315/6 Rajvithi Rd., Bangkok 10400, Thailand.
  • Zhang L; Chengdu Institute of Biological Products Co., Ltd., 379, 3rd, Jinhua Road, Jinjiang District, Chengdu 61002, China.
  • Neuzil KM; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
  • Marfin AA; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
  • Letson GW; Center for Vaccine Innovation and Access, PATH, 2201 Westlake Ave, Suite 200, Seattle, Washington 98121, USA.
Vaccine X ; 10: 100143, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35243320

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine X Año: 2022 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine X Año: 2022 Tipo del documento: Article País de afiliación: Bangladesh Pais de publicación: Reino Unido